Gestational trophoblastic neoplasia epidemiology and demographics: Difference between revisions
No edit summary |
Mahshid |
||
| Line 19: | Line 19: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gynecology]] | |||
[[Category:Surgery]] | |||
Revision as of 23:36, 26 November 2017
|
Gestational trophoblastic neoplasia Microchapters |
|
Differentiating Gestational trophoblastic neoplasia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gestational trophoblastic neoplasia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Gestational trophoblastic neoplasia epidemiology and demographics |
|
FDA on Gestational trophoblastic neoplasia epidemiology and demographics |
|
CDC on Gestational trophoblastic neoplasia epidemiology and demographics |
|
Gestational trophoblastic neoplasia epidemiology and demographics in the news |
|
Blogs on Gestational trophoblastic neoplasia epidemiology and demographics |
|
Directions to Hospitals Treating Gestational trophoblastic neoplasia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overveiw
The incidence of choriocarcinoma is approximately 110-120 per 100,000 pregnancies.[1]
Epidemiology and Demographics
Incidence
- The reported incidence of choriocarcinoma in the United States is about 110 to 120 per 100,000 pregnancies[1]
- The reported incidence of choriocarcinoma, the most aggressive form of GTD, in the United States is about 2 to 7 per 100,000 pregnancies
- The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is about 0.18 per 100,000 women between the ages of 15 years and 49 years
References
- ↑ 1.0 1.1 General Information About Gestational Trophoblastic Disease National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq/#section/_1. Accessed on October7, 2015